Black Diamond Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Black Diamond Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Black Diamond Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Black Diamond Therapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $121k | 24k | 5.07 |
| 2023-12-31 | $361k | 129k | 2.81 |
| 2023-09-30 | $138k | 48k | 2.87 |
| 2023-06-30 | $6.7M | 1.3M | 5.05 |
| 2023-03-31 | $1.1M | 566k | 1.89 |
| 2022-12-31 | $1.5M | 814k | 1.80 |
| 2022-06-30 | $406k | 165k | 2.46 |
| 2022-03-31 | $178k | 65k | 2.76 |
| 2021-12-31 | $327k | 61k | 5.33 |
| 2021-09-30 | $813k | 96k | 8.46 |
| 2021-06-30 | $1.3M | 106k | 12.20 |
| 2021-03-31 | $803k | 33k | 24.25 |